Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2
|
|
- Sara Warner
- 6 years ago
- Views:
Transcription
1 Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2 January 28, to 3 PM Central Time
2 Continuing Education Credit This course is approved for 2.0 hours CE credit by the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center s Commission on Accreditation (ANCC), the American College of Healthcare Executives (ACHE), and.20 CEU by the International Association for Continuing Education and Training (IACET). To receive credit, participants must attest that they have listened to the program in its entirety, and submit a completed online evaluation after the program. 4
3 Continuing Education Credit Because The Joint Commission is an accredited provider of continuing education, participants attending this event will receive continuing education certificates of completion after submitting a completed post-evaluation. A link to the post-evaluation will be sent via to all registered participants after the close of this program. The link to the post-evaluation will remain open until February 6, Please complete and return your evaluation prior to this date to receive credit. 5
4 Disclosure The speaker has disclosed that she does not have any financial arrangements or affiliations with corporate organizations that either provide educational grants to this program or may be referenced in this activity. 6
5 Karen Kolbusz, RN, BSN, MBA Associate Project Director Division of Healthcare Quality Evaluation The Joint Commission
6 Session 2 Review the new comprehensive stroke (CSTK) measures CSTK-05 CSTK-08 CSTK-07 CSTK-02 Provide opportunity for questions 8
7 The Final CSTK Measure Set CSTK-01: National Institutes of Health Stroke Scale (NIHSS) Score Performed for Ischemic Stroke Patients CSTK-02: Modified Rankin Score (mrs) at 90 Days CSTK-03: Severity Measurement Performed for Subarachnoid Hemorrhage (SAH) and Intracerebral Hemorrhage (ICH) Patients (Overall Rate) CSTK-04: Procoagulant Reversal Agent Initiation CSTK-05: Hemorrhagic Transformation (Overall Rate) CSTK-06: Nimodipine Treatment Administered CSTK-07: Median Time to Revascularization CSTK-08: Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade 9
8 Disease-Specific Care CERTIFICATION PROGRAM Comprehensive Stroke PERFORMANCE MEASUREMENT IMPLEMENTATION GUIDE January 2015
9 Three Sub-populations Ischemic stroke patients without intervention (1) Ischemic stroke patients with IV t-pa, IA t-pa, or mechanical reperfusion (MER) therapy (2) Hemorrhagic Stroke Patients (3) Subarachnoid hemorrhage Intracerebral hemorrhage 11
10 CSTK Initial Patient Population ICD-9-CM Principal Diagnosis Code for ischemic or hemorrhagic stroke Patient Age (Admission Date minus Birthdate) > 18 years Length of Stay (Discharge Date minus Admission Date) < 120 days
11 Initial Patient Population con t 3 ICD-9-CM Principal Diagnosis Code for ischemic or hemorrhagic stroke 1 2 ICD-9-CM Principal or Other Procedure Code for thrombolytic therapy or mechanical endovascular reperfusion therapy
12 Data Elements Admission Date Birthdate Discharge Date ICD-9-CM Other Procedure Codes ICD-9-CM Principal Diagnosis Code ICD-9-CM Principal Procedure Codes Note: The initial patient population is the foundation for each individual measure denominator population. 14
13 Excluded Populations Patients less than 18 years of age Patients who have a Length of Stay greater than 120 days Initial patient population algorithm Note: Excluded from each individual measure denominator population. 15
14 CSTK-05 Hemorrhagic Transformation Rationale: Intravenous (IV) thrombolytic (t-pa) therapy for acute ischemic stroke was approved by the US Food and Drug Administration in 1996, following findings from the National Institute of Neurological Disorders and Stroke (NINDS) trial which demonstrated favorable outcomes in 31% to 50% of patients treated with recombinant tissue plasminogen activator (r-tpa), as compared to 20% to 38% of patients treated with placebo. Intra-arterial (IA) thrombolytic therapy (t-pa) has since been used to improve recanalization and clinical outcomes for select patients nonresponsive to IV therapy Mechanical endovascular thrombectomy is a treatment option for patients with large vessel occlusions in whom pharmacological thrombolysis is contraindicated or might be ineffective Type of Measure: Outcome 16
15 CSTK-05 Hemorrhagic Transformation Denominator: Ischemic stroke patients treated with IV t-pa only (IVO), IA t-pa, or mechanical endovascular reperfusion (MER) therapy Numerator: Ischemic stroke patients who develop a symptomatic intracranial hemorrhage < 36 hours after the onset of treatment with IV t-pa, IA t-pa, or MER therapy 17
16 Stratified by Procedure Code and Route of t-pa Administration CSTK-05a Intravenous (IV) thrombolytic (t-pa) therapy only CSTK-05b Intra-arterial (IA) thrombolytic (t-pa) therapy, or Mechanical endovascular reperfusion (MER) therapy
17 CSTK-05 Hemorrhagic Transformation Denominator: Ischemic stroke patients treated with IV t-pa only (IVO), IA t-pa, or mechanical endovascular reperfusion (MER) therapy Sub-Population: CSTK 2 Ischemic Stroke With IV t-pa, IA t-pa, or MER 19
18 CSTK-05 Included Populations Denominator: Discharges with an ICD-9-CM Principal Diagnosis Code for ischemic stroke as defined in Appendix A, Table 8.1, AND 20
19 CSTK-05 Included Populations Denominator: Patients with documented thrombolytic (IV or IA t-pa) therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1a), OR Table 8.1a Thrombolytic Agent Procedures Code Shortened Description INJECTION OR INFUSION OF THROMBOLYTIC AGENT 21
20 CSTK-05 Included Populations Denominator: Patients with documented Mechanical Endovascular Reperfusion Therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1b) Table 8.1b Code Mechanical Endovascular Reperfusion Procedures Shortened Description ENDOVASC EMBOL HD/NK VES ENDO REM OBS HD/NECK VES ENDO EMB HD/NK BARE COIL ENDO EM HD/NK, BIOAC COIL 22
21 CSTK-05 Excluded Populations Denominator: Patients admitted for Elective Carotid Intervention Patients transferred to this hospital following treatment with IV or IA thrombolytic (t-pa) therapy or mechanical endovascular reperfusion therapy initiated prior to arrival at this hospital 23
22 CSTK-05 Excluded Populations Denominator: Patients who hemorrhage prior to the onset of treatment with IV or IA thrombolytic (t-pa) therapy or mechanical endovascular reperfusion therapy 24
23 CSTK-05 Data Elements Denominator: Elective Carotid Intervention ICD-9-CM Other Diagnosis Codes ICD-9-CM Other Procedure Dates ICD-9-CM Principal Procedure Date Measure specific data elements 25
24 CSTK-05 Algorithm Highlights Measure Category X = Missing/Invalid Data Measure Category B = Exclusion
25 CSTK-05 Hemorrhagic Transformation Numerator: Ischemic stroke patients who develop a symptomatic intracranial hemorrhage < 36 hours after the onset of treatment with IV t-pa, IA t-pa, or MER therapy 27
26 CSTK-05 Data Elements Numerator: Arrival Date Arrival Time Highest NIHSS Score Documented Within 36 Hours Following IA t-pa or MER Initiation Highest NIHSS Score Documented Within 36 Hours Following IV Thrombolytic Initiation 28
27 CSTK-05 Data Elements Numerator: IA Route of t-pa Administration IA t-pa or MER Initiation Date IA t-pa or MER Initiation Time IV Thrombolytic Initiation Date IV Thrombolytic Initiation Time 29
28 CSTK-05 Algorithm Highlights Subpopulation CSTK 2 IV t-pa only patients IA t-pa or MER patients
29 CSTK-05 Algorithm Highlights IA t-pa or MER path IA t-pa or MER procedure done at your hospital
30 CSTK-05 Data Elements Numerator: NIHSS Score Documented Closest to IA t-pa or MER Initiation NIHSS Score Documented Closest to IV Thrombolytic Initiation Positive Brain Image Positive Brain Image Date Positive Brain Image Time 32
31 CSTK-05 Algorithm Highlights Within 36 hours
32 CSTK-05 Algorithm Highlights Sequence repeated for IVO path (Timing II, Timing IV, Deterioration 2 Measure Category E = Numerator
33 CSTK-05 DE Definition Example: 35
34 IA Route of t-pa Administration Notes for Abstraction: If both IV and IA thrombolysis are given either in different procedures or the same procedure, select Yes If the only route of thrombolytic administration was intra-venous (IV) at this hospital or a transferring hospital, select No If IA t-pa given at a transferring hospital and NOT your hospital, select NO 36
35 IA Thrombolytic Initiation Date / IA Thrombolytic Initiation Time Notes for Abstraction: If date / time is unable to be determined, select UTD Look for a documented infusion time or start time of the IA thrombolytic bolus or infusion in the medical record Use the time IA thrombolytic was first documented. Multiple times or a discrepancy, choose the earliest time 37
36 NIHSS Score Documented Closest to IA t-pa or MER Initiation Definition: The NIHSS score documented closest to IA thrombolytic (t-pa) therapy or mechanical endovascular reperfusion (MER) therapy initiation is the last NIHSS score documented prior to IA t-pa or MER initiation (i.e., the initiation time of the intervention performed first) at this hospital 38
37 NIHSS Score Documented Closest to IA t-pa or MER Initiation Data Collection Question: What is the last NIHSS score documented prior to initiation of IA t-pa or MER at this hospital? Allowable Values: Score = 0-42 UTD = Unable to Determine 39
38 NIHSS Score Documented Closest to IA t-pa or MER Initiation Notes for Abstraction: Documented by the physician/apn/pa or nurse (RN) Select the last NIHSS score documented prior to the start time of IA t-pa OR first pass of a mechanical reperfusion device whichever intervention is performed first, (i.e. IA t-pa first then MER or MER first then IA t-pa ), at this hospital 40
39 NIHSS Score Documented Closest to IA t-pa or MER Initiation Notes for Abstraction: If only one NIHSS score is documented prior to IA t-pa or MER initiation, enter the value for that score If no NIHSS score is documented prior to IA t-pa or MER initiation, select UTD. If unable to determine the last NIHSS score documented prior to IA t-pa or MER initiation, select UTD 41
40 NIHSS Score Documented Closest to IA t-pa or MER Initiation Exclusion Guidelines for Abstraction: Modified NIHSS scores Estimated NIHSS scores Scoring methodologies other than NIHSS Note: Exclusion Guidelines for Abstraction listed in a data element means that these items do NOT count select NO 42
41 Highest NIHSS Score Documented Within 36 Hours Following IA t-pa or MER Initiation Notes for Abstraction: Look for the highest NIHSS score documented in less than or equal to 36 hours following initiation of IA t-pa or MER therapy If multiple scores are documented within the first 36 hours following initiation of IA t-pa or MER therapy, select the highest 43
42 Positive Brain Image Notes for Abstraction: Documentation of a positive finding on brain imaging of parenchymal hematoma, subarachnoid hemorrhage, and/or intraventricular hemorrhage following IV or IA t-pa, OR MER therapy initiation The major risk of reperfusion therapy is hemorrhage 44
43 Positive Brain Image Notes for Abstraction: For purposes of this data element, do not use brain imaging reports for CT/MRI performed prior to IV or IA thombolytic (t-pa) initiation, or mechanical endovascular reperfusion (MER) therapy Abstract only brain imaging reports for tests done after these interventions to select YES 45
44 Positive Brain Image Notes for Abstraction: For patients with a positive finding of hemorrhage on brain imaging following IV or IA t-pa or MER initiation, select YES A confirmed report is not necessary. Reports of preliminary findings within this timeframe may be used in abstraction Findings suggestive of hemorrhage or conflicting documentation, select YES 46
45 Positive Brain Image ONLY acceptable data sources: Brain imaging reports Diagnostic test reports Radiology reports 47
46 Positive Brain Image Inclusion Terms Bleed Brain hemorrhage Cerebral hemorrhage ECASS criteria PH1 or PH2 Hemorrhage Hemorrhagic conversion Hemorrhagic expansion Hemorrhagic transformation Intracerebral hemorrhage (ICH) Intraventricular hemorrhage Parenchymal hematoma Parenchymal hemorrhage Parenchymal intracerebral hemorrhage Petechial hemorrhage Subarachnoid hemorrhage (SAH)
47 Positive Brain Image Date / Time Notes for Abstraction: Use the first documented date/time of positive brain image finding following IV or IA t-pa, or MER therapy If a discrepancy exists in date/time documentation from different sources, choose the earliest date Two or more different positive brain image dates, enter the earliest date Unable to be determine, select UTD 49
48 CSTK-05 Algorithm Highlights CSTK-05 Overall Rate Measure Category Assignments IV t-pa only patients IA t-pa or MER patients
49
50 CSTK-08 TICI Post-Treatment Reperfusion Grade Rationale: The Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade is used to measure cerebral reperfusion. Four results are possible with this scoring system: 0 (no perfusion); 1 (perfusion past the initial occlusion, but no distal branch filling); 2 (perfusion with incomplete or slow distal branch filling); and 3 (full perfusion with filling of all distal branches)... The Interventional Management of Stroke (IMS) I trial suggested that the combined use of reduced-dose intravenous (IV) thrombolytic (t-pa) therapy, followed by microcatheter delivered intra-arterial (IA) thrombolytic (t-pa) therapy, was safe and effective in selected ischemic stroke patients, as compared to patients treated with full dose IV t-pa in the National Institute of Neurologic disease and Stroke (NINDS) rt-pa trial. In IMS I, a final TICI 2/3 reperfusion was achieved in 62% of ischemic stroke patients treated. Type of Measure: Outcome 52
51 CSTK-08 TICI Post-Treatment Reperfusion Grade Denominator: Ischemic stroke patients treated with IA t-pa and or MER therapy Numerator: Ischemic stroke patients with a post-treatment reperfusion grade of TICI 2B or higher 53
52 CSTK-08 TICI Post-Treatment Reperfusion Grade Denominator: Ischemic stroke patients treated with IA t-pa and or MER therapy Sub-Population: CSTK 2 Ischemic Stroke With IV t-pa, IA t-pa, or MER 54
53 CSTK-08 Included Populations Denominator: Discharges with an ICD-9-CM Principal Diagnosis Code for ischemic stroke as defined in Appendix A, Table 8.1, AND 55
54 CSTK-08 Included Populations Denominator: Patients with documented thrombolytic (IV or IA t-pa) therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1a), OR Table 8.1a Thrombolytic Agent Procedures Code Shortened Description INJECTION OR INFUSION OF THROMBOLYTIC AGENT 56
55 CSTK-08 Included Populations Denominator: Patients with documented Mechanical Endovascular Reperfusion Therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1b) Table 8.1b Code Mechanical Endovascular Reperfusion Procedures Shortened Description ENDOVASC EMBOL HD/NK VES ENDO REM OBS HD/NECK VES ENDO EMB HD/NK BARE COIL ENDO EM HD/NK, BIOAC COIL 57
56 CSTK-08 Excluded Populations Denominator: Patients admitted for Elective Carotid Intervention 58
57 CSTK-08 Data Elements Denominator: Elective Carotid Intervention IA Route of t-pa Administration Measure specific data elements 59
58 CSTK-08 Algorithm Highlights No IA = IV t-pa, Case excluded; Yes IA, case included
59 CSTK-08 TICI Post-Treatment Reperfusion Grade Numerator: Ischemic stroke patients with a post-treatment reperfusion grade of TICI 2B or higher 61
60 CSTK-08 Data Elements Numerator: Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade 62
61 Post-Treatment TICI Definition: Documentation that the Thrombolysis in Cerebral Infarction (TICI) reperfusion grade was 2B (i.e., partial perfusion greater than or equal to 50% of vascular distribution of occluded artery) or higher post-treatment. 63
62 Post-Treatment TICI Allowable Values: 1 A TICI reperfusion grade greater than or equal to ( ) 2B was documented posttreatment 2 A TICI reperfusion grade less than (<) 2B was documented post-treatment 3 A TICI reperfusion grade was not done post-treatment, OR Unable to determine (UTD) from the medical record documentation 64
63 Post-Treatment TICI Notes for Abstraction: Physician/APN/PA documentation of the TICI grade only Exclusion Guidelines for Abstraction: TIBI TIMI Scoring methodologies other than TICI 65
64 CSTK-08 Algorithm Highlights 2 = < TICI 2B 3 = UTD Measure Category E = Numerator 1 = > TICI 2B
65 Risk Adjustment Data Elements Outcome measures need to be adjusted for risk Risk Adjustment data elements are collected of CSTK-05 and CSTK-08 Risk adjustment data elements are NOT used in the algorithms to calculate the measure rate Risk adjustment data elements are patientlevel data collected to develop the risk adjustment model for these measures 67
66 Risk Adjustment Data Elements Admission Date Birthdate Hispanic Ethnicity ICD-9-CM Other Diagnosis Codes IV Thrombolytic Therapy Prior to IA or Mechanical Reperfusion Therapy Initial Blood Glucose Value at Hospital Arrival Initial Blood Pressure at Hospital Arrival Initial NIHSS Score at Hospital Arrival Initial Platelet Count at Hospital Arrival Proximal or Distal Occlusion Race Sex Site of Primary Vessel Occlusion
67 Abstraction Tips Note the Format for data entry detailed in the data element definition Initial Platelet Count at Hospital Arrival requires a 6 character value, no comma, no decimal (e.g., ) Use abstraction guidelines to help identify acceptable values, e.g., location of testing, testing methods such as Point of Care (POC) Review values obtained prior to and after hospital arrival to select the earliest value 69
68 Abstraction Tips Initial NIHSS Score at Hospital Arrival is the earliest documented NIHSS score and may have been done by EMS, teleneurology or a transferring hospital. The data element definition is NOT the same as the definition for Initial NIHSS Score Performed (CSTK-01) Initial NIHSS Score Performed asks for scores done at your hospital, allowable values Yes / No 70
69
70 CSTK-07 Median Time to Revascularization Rationale: Timely recanalization of an occluded intracerebral artery is a strong predictor of improved functional outcome and reduced mortality in patients with an acute ischemic stroke. At this time, administration of intra-venous (IV) tissue plasminogen activator (t-pa) within three hours of time last known well remains the recommended first-line approach. However, the short therapeutic window and low rates of recanalization with IV thrombolytic (t- PA) therapy has prompted the investigation of alternative approaches via intra-arterial infusion of a thrombolytic drug or mechanical recanalization with a clot retrieval device. Since time is brain, the overall speed of the revascularization process is an important and appropriate measure. It is estimated that for every 30-minute delay in time to revascularization, there is a 10% decrease in the likelihood of a good outcome from endovascular reperfusion therapy. Type of Measure: Process 72
71 CSTK-07 Median Time to Revascularization Continuous Variable Statement: Time (in minutes) from hospital arrival to the start of an intra-arterial (IA) thrombolytic (t-pa) infusion or the first pass of a mechanical reperfusion device in patients with acute ischemic stroke who undergo revascularization therapy Sub-Population: CSTK 2 Ischemic Stroke With IV t-pa, IA t-pa, or MER 73
72 CSTK-07 Included Populations Discharges with an ICD-9-CM Principal Diagnosis Code for ischemic stroke as defined in Appendix A, Table 8.1, AND 74
73 CSTK-07 Included Populations Patients with documented thrombolytic infusion therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1a), OR Table 8.1a Thrombolytic Agent Procedures Code Shortened Description INJECTION OR INFUSION OF THROMBOLYTIC AGENT 75
74 CSTK-07 Included Populations Patients with documented Mechanical Endovascular Reperfusion Therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1b) Table 8.1b Code Mechanical Endovascular Reperfusion Procedures Shortened Description ENDOVASC EMBOL HD/NK VES ENDO REM OBS HD/NECK VES ENDO EMB HD/NK BARE COIL ENDO EM HD/NK, BIOAC COIL 76
75 CSTK-07 Excluded Populations Patients admitted for Elective Carotid Intervention 77
76 CSTK-07 Data Elements Arrival Date Arrival Time Elective Carotid Intervention First Pass of a Mechanical Reperfusion Device First Pass Date First Pass Time 78
77 CSTK-07 Data Elements IA Route of t-pa Administration IA Thrombolytic Initiation IA Thrombolytic Initiation Date IA Thrombolytic Initiation Time Measure specific data elements 79
78 CSTK-07 Algorithm Highlights IA Route of t-pa Administration = No excludes IV t-pa patients, Measure Category B MER patients 2 Patient Paths IA t-pa patients
79 First Pass of a Mechanical Reperfusion Device Definition: First pass (i.e., deployment) of a mechanical reperfusion device to remove a clot occluding a cerebral artery at this hospital. A mechanical reperfusion device is also known as a clot retrieval device. Clot retrieval devices are designed to treat ischemic stroke by removal of the clot from the cerebral artery. Several brand names are used to identify clot retrieval devices which include, Merci, Penumbra, Trevo, and Solataire. For purposes of this data element, pass means mechanical deployment of a clot retrieval device 81
80 First Pass of a Mechanical Reperfusion Device Data Collection Question: Is there documentation in the medical record of the first pass of a mechanical reperfusion device to remove a clot occluding a cerebral artery at this hospital? Allowable Values: YES NO 82
81 First Pass of a Mechanical Reperfusion Device Notes for Abstraction: If the first pass of the mechanical reperfusion device at this hospital is unable to be determined from medical record documentation, select No If a diagnostic test report conflicts with other sources documenting the first pass of a mechanical reperfusion device to remove a clot occluding a cerebral artery, use the documentation found in the diagnostic test report 83
82 First Pass of a Mechanical Reperfusion Device Inclusion Guidelines for Abstraction: Deployment Pass Suggested Data Sources: Consultation notes Diagnostic test reports Operative notes Procedure reports 84
83 First Pass Date / Time Notes for Abstraction: If the date / time of the first pass is unable to be determined from medical record documentation, select UTD The earliest time should be used regardless of how many vessels were treated or which ones were successful vs. unsuccessful 85
84 IA Thrombolytic Initiation Notes for Abstraction: If the data element IA Route of t-pa Administration is "Yes", select "Yes" for IA Thrombolytic Initiation Look for a start time or infusion time for IA thrombolytic If IA thrombolytic initiation is unable to be determined from medical record documentation, select No 86
85 CSTK-07 Algorithm Highlights 2 Patient Paths First Pass Date and Time collected for patients who have A MER procedure IA Thrombolytic Initiation Date and Time collected for patients who get IA t-pa Patients who get IA t-pa and MER have First Pass Date and Time, AND IA Thrombolytic Date and Time
86 CSTK-07 Algorithm Highlights IA t-pa and MER paths joined in IAMER path Algorithm selects the earliest date and time from multiple First Pass and IA Thrombolytic Dates and Times entered
87 CSTK-07 Algorithm Highlights Earliest procedure date and time minus Arrival Date and Arrival Time = Median Time in minutes (i.e., time > 0 min.) Continuous Variable, Measure Category Y
88
89 CSTK-02 mrs at 90 Days Rationale: The Modified Rankin Scale (mrs) is the accepted standard for assessing recovery post-stroke. As such, it has become the most widely used clinical outcome measure for stroke clinical trials. Scores are used to measure the degree of disability or dependence in activities of daily living. Score reliability and reproducibility are improved through use of a structured interview by a trained evaluator. Interviews may be conducted in-person or over the phone. According to guideline recommendations from the American Heart Association/American Stroke Association, standardized interviews to obtain a mrs score should be conducted for acute ischemic stroke patients treated with IV or IA thrombolytic (t-pa) therapy or mechanical endovascular reperfusion therapy at 3 months (90 days); however, recovery may continue well beyond 3 months for many ischemic stroke patients. Type of Measure: Process 91
90 CSTK-02 mrs at 90 Days Denominator: Ischemic stroke patients treated with IV or IA thrombolytic (t-pa) therapy or who undergo mechanical endovascular reperfusion therapy Numerator: Ischemic stroke patients for whom a 90 day ( > 75 days and < 105 days) mrs is obtained via telephone or in-person 92
91 CSTK-02 mrs at 90 Days Denominator: Ischemic stroke patients treated with IV or IA thrombolytic (t-pa) therapy or who undergo mechanical endovascular reperfusion therapy Sub-Population: CSTK 2 Ischemic Stroke With IV t-pa, IA t-pa, or MER 93
92 CSTK-02 Included Populations Denominator: Discharges with an ICD-9-CM Principal Diagnosis Code for ischemic stroke as defined in Appendix A, Table 8.1, AND 94
93 CSTK-02 Included Populations Denominator: Patients with documented thrombolytic (IV or IA t-pa) therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1a), OR Table 8.1a Thrombolytic Agent Procedures Code Shortened Description INJECTION OR INFUSION OF THROMBOLYTIC AGENT 95
94 CSTK-02 Included Populations Denominator: Patients with documented Mechanical Endovascular Reperfusion Therapy (ICD-9-CM Principal or Other Procedure Codes as defined in Appendix A, Table 8.1b) Table 8.1b Code Mechanical Endovascular Reperfusion Procedures Shortened Description ENDOVASC EMBOL HD/NK VES ENDO REM OBS HD/NECK VES ENDO EMB HD/NK BARE COIL ENDO EM HD/NK, BIOAC COIL 96
95 CSTK-02 Excluded Populations Denominator: Patients admitted for Elective Carotid Intervention Patients who expire during the hospital stay 97
96 CSTK-02 Data Elements Denominator: Discharge Disposition Elective Carotid Intervention Measure specific data elements 98
97 CSTK-02 Algorithm Highlights Patients who expire (= 6) during the hospital stay are excluded
98 CSTK-02 mrs at 90 Days Numerator: Ischemic stroke patients for whom a 90 day ( > 75 days and < 105 days) mrs is obtained via telephone or in-person Included Populations: As above Excluded Populations: None 100
99 CSTK-02 Data Elements Numerator: Modified Rankin Score (mrs) Modified Rankin Score (mrs) Date 101
100 Modified Rankin Score (mrs) Definition: Documentation in the medical record of a Modified Rankin Score (mrs). The Modified Rankin Score (mrs) is a 6 point disability scale with possible scores ranging from 0 to 5. A separate category of 6 is usually added for patients who expire. The Modified Rankin Score (mrs) is the most widely used outcome measure in stroke clinical trials. Standardized interviews to obtain a mrs score are recommended at 3 months (90 days) following hospital discharge 102
101 Modified Rankin Score (mrs) Data Collection Question: What is the patient s Modified Rankin Score (mrs) at 90 days post-discharge? Allowable Values: 0 through 8 6 used for patients who expire after hospital discharge 7 Unable to contact patient/caregiver 8 Modified Rankin Score not performed, OR unable to determine (UTD) from the medical record documentation 103
102 Modified Rankin Score (mrs) Notes for Abstraction: Documented by the physician/apn/pa or nurse (RN), medical assistant, or any individual trained to perform the mrs If more than one value is documented at 90 days, select the highest value If a score range is documented, e.g. 2-3, select the higher value 3 If no mrs is documented, select 8 UTD 104
103 Modified Rankin Score (mrs) Notes for Abstraction: In-person or telephone interviews are acceptable Caregiver may be interviewed if unable to interview the patient Three or more unsuccessful attempts to contact the patient/caregiver, select 7 Patient/caregiver refusal, language barriers without an available translator, HIPPA issues, select 7 105
104 Modified Rankin Score Date Notes for Abstraction: Multiple dates or discrepancy documented, use the earliest date in the 90-day period Dates before 75 days or after 90 days, use the date closest to the 90-day period For patients who expire after hospital discharge, select the date of the interview Unsuccessful attempts, date of the last attempt to contact the patient/caregiver Unable to determine date, select 8 UTD 106
105 CSTK-02 Algorithm Highlights Allowable value 8 only, sends case to Measure Category D mrs Date within 90 days, Measure Category E = Numerator mrs Date outside 90 days, Measure Category D
106
107 New Performance Measure Requirements for CSC Data collection for 8 new CSTK measures effective January 1, 2015 Ongoing data collection for the 8 STK core measures Mandatory data collection requirement for 16 performance measures total 109
108 Data Collection Tools Vendors may be used to submit CSTK data to The Joint Commission Contact your Account Executive to choose a vendor Vendor selection is not linked with STK core vendor Comparion Medical Analytics Midas+ Miosoft Nuance Communications Quantros Quintiles (GWTG)
109 Continuing Education Credit To receive credit, participants must Attest that they have listened to the program in its entirety, and Complete and return the post-course evaluation to The Joint Commission by February 6, 2015 A link to the post-course evaluation will be sent to all registered attendees following this program Certificates of Attendance will be sent via by February 20, 2015 Print a certificate 111
110 Direct questions to
111 Thank You
Mechanical Endovascular Reperfusion Therapy
Get With the Guidelines Stroke Mechanical Endovascular Reperfusion Therapy February 1, 2017 Speaker Lee H. Schwamm, MD Executive Vice Chairman and Director of Stroke/TeleStroke Services, Department of
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationStroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University
More informationComprehensive Stroke Performance Measurement Implementation Guide
Comprehensive Stroke Performance Measurement Implementation Guide Release Notes Version: 2015Jul Release Notes Completed: June 30, 2015 Guidelines for Using Release Notes Release Notes 2015Jul provide
More informationStroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center
Stroke Update 2015 Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center Objectives 1. Review successes in systems of care approach to acute ischemic stroke
More informationAntithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding
Get With The Guidelines -Stroke is the American Heart Association s collaborative performance improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized with
More informationVote Using Your Phone!
Update on Stroke Certification Jean Range, MS, RN The Joint Commission February 28, 2014 Vote Using Your Phone! Answer multiple choice questions by texting a code to 22333. Your phone carrier s texting
More informationAdvances in Neuro-Endovascular Care for Acute Stroke
Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center
More informationPrimary Versus Comprehensive: What is the Difference?
Primary Versus Comprehensive: What is the Difference? April 26, 2018 Bethann Mercanti, PA-C Director of Clinical Practice Stroke Program Coordinator Cooper Neurological Institute Cooper Bon & Joint Institute
More informationENDOVASCULAR THERAPIES FOR ACUTE STROKE
ENDOVASCULAR THERAPIES FOR ACUTE STROKE Cerebral Arteriogram Cerebral Anatomy Cerebral Anatomy Brain Imaging Acute Ischemic Stroke (AIS) Therapy Main goal is to restore blood flow and improve perfusion
More informationTENNESSEE STROKE REGISTRY QUARTERLY REPORT
TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 3 September 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender
More informationframework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow
Acute Stroke Treatment Collaterals in Acute Ischemic Stroke Objectives role of collaterals in acute ischemic stroke collateral therapeutic strategies David S Liebeskind, MD Professor of Neurology & Director
More informationCOMPREHENSIVE SUMMARY OF INSTOR REPORTS
COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list
More informationGet With the Guidelines Stroke PMT. Quality Measure Descriptions
Get With the Guidelines Stroke PMT Quality Measure s Last Updated July 2016 Print Measure s Dysphagia Screen Stroke Education Rehabilitation Considered Time to Intravenous Thrombolytic Therapy 60 min LDL
More informationAcute Stroke Treatment: Current Trends 2010
Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment
More informationEmergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)
2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement
More informationUPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015
UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015 NEW STUDIES FOR 2015 MR CLEAN ESCAPE EXTEND-IA REVASCAT SWIFT PRIME RECOGNIZED LIMITATIONS IV Alteplase proven benefit
More informationDisclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD
Advances in Interventional Neurology Disclosure Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationHow to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval
How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval Peter Howard MD FRCPC Disclosures No conflicts to disclose How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular
More informationEndovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials
Published online: March 13, 2015 1664 9737/15/0034 0115$39.50/0 Review Endovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials Manabu Shirakawa a Shinichi Yoshimura
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationEmergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)
Specifications Description Methodology NIH Stroke Scale (NIHSS) Performed in Initial Evaluation used to assess the percentage of adult stroke patients who had the NIHSS performed during their initial evaluation
More informationTENNESSEE STROKE REGISTRY QUARTERLY REPORT
TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 2 July 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender distributions,
More informationDrano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients
Drano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients Peter Panagos, MD, FACEP, FAHA Associate Professor Emergency Medicine and Neurology Washington University School
More informationBroadening the Stroke Window in Light of the DAWN Trial
Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University
More informationACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in
More informationEndovascular Treatment Updates in Stroke Care
Endovascular Treatment Updates in Stroke Care Autumn Graham, MD April 6-10, 2017 Phoenix, AZ Endovascular Treatment Updates in Stroke Care Autumn Graham, MD Associate Professor of Clinical Emergency Medicine
More informationThe Joint Commission: Comprehensive Overview of Advanced Stroke & Advance Heart Failure Programs
The Joint Commission: Comprehensive Overview of Advanced Stroke & Advance Heart Failure Programs WA State Cardiac & Stroke Conference Brian R. Johnson, Ph.D. Associate Director Hospital Business Development
More informationMoving from a Primary Stroke Center to a Comprehensive Stroke Center
Moving from a Primary Stroke Center to a Comprehensive Stroke Center MJ Hampel, MPH, MBA The Joint Commission October 19, 2012 Presenter Disclosure Information MJ Hampel Moving from a Primary Stroke Center
More informationFigures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials
Figures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials Figure 1: Lay Press Judgment May Belie a Deeper Examination of the Data. Truman ultimately defeated Dewey for the Presidency Subject
More informationMechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices
Mechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices Joey English MD, PhD Medical Director, Neurointerventional Services California Pacific Medical Center Hospitals, San Francisco,
More informationDisclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!
Disclosures Anesthesia for Endovascular Treatment of Acute Ischemic Stroke I have nothing to disclose. Chanhung Lee MD, PhD Associate Professor Anesthesia and perioperative Care Acute Ischemic Stroke 780,000
More informationRelease Notes for the 2018B Manual
Release Notes for the 2018B Manual Measure Information Forms Section Rationale Description ASR-IP-1 ASR-IP-2 ASR-IP-3 ASR-OP-1 ASR-OP-2 Update references and measure rationale to include new clinical practice
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationParameter Optimized Treatment for Acute Ischemic Stroke
Heart & Stroke Barnett Memorial Lectureship and Visiting Professorship Parameter Optimized Treatment for Acute Ischemic Stroke December 2, 2016, Thunder Bay, Ontario Adnan I. Qureshi MD Professor of Neurology,
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationThe DAWN of a New Era for Wake-up Stroke
The DAWN of a New Era for Wake-up Stroke Alan H. Yee, D.O. Stroke and Critical Care Neurology Department of Neurology University of California Davis Medical Center Objectives Review Epidemiology and Natural
More informationInterventional Stroke Treatment
Interventional Stroke Treatment Vishal B. Jani MD Medical Director Vascular Neurology Consultant Interventional Neurology CHI Health Assistant Professor, Creighton University School of Medicine Omaha,
More informationJAWDA Quarterly Waiting Time Guidelines for (Specialized and General Hospitals)
JAWDA Waiting Time Guidelines for (Specialized and General Hospitals) January 2019 Page 1 of 22 Table of Contents Executive Summary... 3 About this Guidance... 4 Performance Indicators... 5 APPENDIX -
More informationStroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP
Stroke: The First Critical Hour Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP Disclosures We have no actual or potential conflicts of interest in relation to this presentation. Objectives Discuss
More informationThe Multi arm Optimization of Stroke Thrombolysis (MOST) Trial
The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial Study Team Principal Investigators: Opeolu Adeoye, University of Cincinnati (Lead) Andrew Barreto, University of Texas Houston Jim Grotta,
More informationEndovascular Treatment of Ischemic Stroke
Endovascular Treatment of Ischemic Stroke William Thorell, MD Associate Professor Neurosurgery UNMC Co-Director Stroke and Neurovascular Center Nebraska Medicine Overview Definitions of terms Review basic
More informationAcute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center
Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting
More informationCase 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE Rhonda Whiteman Racing Against the Clock Workshop June 1, 2017 Objectives To discuss the hyperacute ischemic stroke management
More informationUpdate on Early Acute Ischemic Stroke Interventions
Update on Early Acute Ischemic Stroke Interventions Diana Goodman MD Lead Neurohospitalist Maine Medical Center Assistant Professor of Neurology, Tufts University School of Medicine I have no disclosures
More informationAdvances in Acute stroke Management
Advances in Acute stroke Management Sandra Ripper-Brown, DNP Neuroscience Nurse Practitioner St. Mary s Medical Center WPB, FL Palm Beach County Nurse Practitioner Council Annual Conference APRNs: Agents
More informationDoor to Needle Time: Gold Standard of Stroke Treatment Fatima Milfred, MD. Virginia Mason Medical Center March 16, 2018
Door to Needle Time: Gold Standard of Stroke Treatment Fatima Milfred, MD Virginia Mason Medical Center March 16, 2018 2016 Virginia Mason Medical Center No disclosure 2016 Virginia Mason Medical Center
More informationEpidemiology. Epidemiology 6/1/2015. Cerebral Ischemia
Presenter Disclosure Information Paul Nyquist MD/MPH FCCM FAHA Updates on the Acute Care of Ischemic Stroke and Intracranial Hemorrhage Updates on the Acute Care of Ischemic Stroke Paul Nyquist MD/MPH,
More informationQuality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care
Quality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
More informationHAAD quality KPI; waiting time
Type: Waiting Time Indicator Indicator Number: WT001 Primary Care Appointment- Outpatient Setting Time to see a HAAD licensed family physician or member of their team (GP) Time of request (walk-in or by
More informationSentinel Stroke National Audit Programme (SSNAP) Based on stroke patients admitted to hospital for thrombectomy between April 2016 and March 2017
Thrombectomy Sentinel Stroke National Audit Programme (SSNAP) Thrombectomy Report for April 2016 - March 2017 National results July 2017 Based on stroke patients admitted to hospital for between April
More informationAcute Stroke Rescue and Recovery
Acute Stroke Rescue and Recovery Qaisar A. Shah, MD Director, Neurointerventional and Neurocritical care Nancy Arena Gogal,, RN Manager Cath/EPS/Neuro lab AMH Stroke Program Evolution 1997: Stroke Program
More informationMechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital
Mechanical thrombectomy beyond the 6 hours Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital Disclosures None Worldwide statistics 1 IN 6 people will have a stroke at some
More informationHistorical. Medical Policy
Medical Policy Subject: Mechanical Embolectomy for Treatment of Acute Stroke Policy #: SURG.00098 Current Effective Date: 01/01/2016 Status: Revised Last Review Date: 08/06/2015 Description/Scope This
More informationAlex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and
Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and Interventional Neurology Fellowships University of Louisville School
More informationACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS
Associate Professor of Neurology Director of Neurointerventional Services University of Louisville School of Medicine ACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS Conflict of Interest
More informationSupplementary Online Content
Supplementary Online Content Badhiwala JH, Nassiri F, Alhazzani W, et al. Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. JAMA. doi:10.1001/jama.2015.13767. etable 1. The modified
More informationEndovascular Neurointervention in Cerebral Ischemia
Endovascular Neurointervention in Cerebral Ischemia Beyond Thrombolytics Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington 72 y/o female with a recent diagnosis
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationMechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016
Mechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016 none DISCLOSURES Where did we come from? Spiotta, et
More informationDisclosures. Current Management of Acute Ischemic Stroke. Overview. Focal brain ischemia. Nerissa U. Ko, MD, MAS Professor of Neurology May 8, 2015
Disclosures Current Management of Acute Ischemic Nerissa U. Ko, MD, MAS Professor of Neurology May 8, 2015 Nothing to disclose Research Funding: American Heart Association NIH/NINDS Selected slides courtesy
More informationBenjamin Fox, MD Medical Director: Neurointerventional Radiology (NIR) DRMC Medical Director: Neurosurgery & Neurovascular, Intermountain Healthcare
Update on neurointerventional (NIR) services at Dixie Regional Medical Center and in the Southwest Region Benjamin Fox, MD Medical Director: Neurointerventional Radiology (NIR) DRMC Medical Director: Neurosurgery
More informationACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE HHS Stroke Annual Review March 7 and March 8, 2018 Objectives To review the stroke endovascular mechanical thrombectomy evidence
More informationAcute Ischemic Stroke Imaging. Ronald L. Wolf, MD, PhD Associate Professor of Radiology
Acute Ischemic Stroke Imaging Ronald L. Wolf, MD, PhD Associate Professor of Radiology Title of First Slide of Substance An Illustrative Case 2 Disclosures No financial disclosures Off-label uses of some
More informationRural emergency department best practice for treatment of acute ischemic stroke
Rural emergency department best practice for treatment of acute ischemic stroke Aubrey J. Hoye, DO Ministry Howard Young Medical Center, Woodruff, WI Ministry Eagle River Memorial Hospital, Eagle River,
More informationHERMES Time and Workflow Primary Paper. Statistical Analysis Plan
HERMES Time and Workflow Primary Paper Statistical Analysis Plan I. Study Aims This is a post-hoc analysis of the pooled HERMES dataset, with the following specific aims: A) To characterize the time period
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationEmergency Department Management of Acute Ischemic Stroke
Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More informationRBWH ICU Journal Club February 2018 Adam Simpson
RBWH ICU Journal Club February 2018 Adam Simpson 3 THROMBOLYSIS Reperfusion therapy has become the mainstay of therapy for ischaemic stroke. Thrombolysis is now well accepted within 4.5 hours. - Improved
More informationDISCLOSURES. Learning Objectives. David Lee Gordon, MD, FAHA Update in Stroke 2007 FINANCIAL DISCLOSURE UNLABELED/UNAPPROVED USES DISCLOSURE
Acute Stroke Care and the Role of EMS Ryan Hakimi, DO, MS April 30, 2015 Assistant Professor Director, Critical Care Neurology Department of Neurology University of Oklahoma Health Sciences Center DISCLOSURES
More informationBGS Spring Conference 2015
Neuroradiology in hyperacute stroke: what is the UK position? Dr Shelley Renowden Bristol NICE HIS July, 2013 The current evidence on mechanical clot retrieval for treating acute ischaemic stroke shows
More informationTreatment for Acute Stroke: A Retrospective Study of Erlanger Stroke Patients from
Southern Adventist Univeristy KnowledgeExchange@Southern Graduate Research Projects Nursing 12-2013 Treatment for Acute Stroke: A Retrospective Study of Erlanger Stroke Patients from 2004-2012 Sarah Henson
More informationPARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET
PARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET Hye Seon Jeong, *Jei Kim Department of Neurology and
More informationAcute basilar artery occlusion (BAO) is associated with a very
ORIGINAL RESEARCH INTERVENTIONAL Acute Basilar Artery Occlusion: Outcome of Mechanical Thrombectomy with Solitaire Stent within 8 Hours of Stroke Onset J.M. Baek, W. Yoon, S.K. Kim, M.Y. Jung, M.S. Park,
More informationStroke Cart Improves Efficiency in Acute Ischemic Stroke Intervention
Stroke Cart Improves Efficiency in Acute Ischemic Stroke Intervention MR Amans, F Settecase, R Darflinger, M Alexander, A Nicholson, DL Cooke, SW Hetts, CF Dowd, RT Higashida, VV Halbach Interventional
More informationBackground. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association An Scientific Statement from the Stroke Council, American Heart Association and American Stroke Association
More informationImaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital
Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Disclosures Penumbra, Inc. research grant (significant) for
More informationORIGINAL RESEARCH. Gabriel A. Vidal, MD, 1,2 James M. Milburn, MD 3
ORIGINAL RESEARCH Ochsner Journal 16:486 491, 2016 Ó Academic Division of Ochsner Clinic Foundation The Penumbra 5MAX ACE Catheter Is Safe, Efficient, and Cost Saving as a Primary Mechanical Thrombectomy
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationAcute brain vessel thrombectomie: when? Why? How?
Acute brain vessel thrombectomie: when? Why? How? Didier Payen, MD, Ph D Université Paris 7 Département Anesthesiologie-Réanimation Univ Paris 7; Unité INSERM 1160 Hôpital Lariboisière AP-HParis current
More informationStrokecenter Key lessons of MR CLEAN study
Strokecenter Key lessons of MR CLEAN study Diederik Dippel Disclosures Funded by the Dutch Heart Foundation Nominal, unrestricted grants from AngioCare BV Medtronic/Covidien/EV3 MEDAC Gmbh/LAMEPRO Penumbra
More informationEndovascular Stroke Therapy
Endovascular Stroke Therapy Update with Emphasis on Practical Clinical and Imaging Considerations Sachin Kishore Pandey, MD, FRCPC Disclosures I have no relevant financial disclosures or conflict of interest
More informationNeuro-vascular Intervention in Stroke. Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust
Neuro-vascular Intervention in Stroke Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust Stroke before the mid 1990s Swelling Stroke extension Haemorrhagic transformation Intravenous thrombolysis
More informationSinus Venous Thrombosis
Sinus Venous Thrombosis Joseph J Gemmete, MD FACR, FSIR, FAHA Professor Departments of Radiology and Neurosurgery University of Michigan Hospitals Ann Arbor, MI Outline Introduction Medical Treatment Options
More informationStroke Systems of Care
Comprehensive Stroke and Cerebrovascular Center Stroke Systems of Care Dana Stradling RN MSN CNRN UC Irvine Stroke Manager dstradli@uci.edu Why Stroke Systems? No. 4 th 5 th cause of death in the U.S.
More informationWHY TIMELINESS MATTERS. W&M Wren Association Lecture Series
WHY TIMELINESS MATTERS April 10, 2018 W&M Wren Association Lecture Series Pankajavalli Ramakrishnan, M.D., Ph.D. Stroke Neurologist and Neurointerventionalist Riverside Regional Medical Center Comprehensive
More informationStroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center. What do we know?
Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center What do we know? Stroke: Time is Brain Shorter onset to treatment times
More informationEvidence for Mechanical ThrombectomyFor Acute Ischemic Stroke. Kenneth V Snyder MD PhD SUNY Buffalo, NY
Evidence for Mechanical ThrombectomyFor Acute Ischemic Stroke Kenneth V Snyder MD PhD SUNY Buffalo, NY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Honorarium
More informationFrom interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
More informationStroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA
Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American
More informationBY MARILYN M. RYMER, MD
Lytics, Devices, and Advanced Imaging The evolving art and science of acute stroke intervention. BY MARILYN M. RYMER, MD In 1996, when the US Food and Drug Administration (FDA) approved the use of intravenous
More information5/31/2018. Interventional Therapies that Expand Time Windows for Acute Ischemic Stroke Treatment. Disclosures. Impact of clot burden
Good Outcome (%) Rankin 0-2 at 90 days 5/31/2018 Interventional Therapies that Expand Time Windows for Acute Ischemic Stroke Treatment Disclosures Cerenovus: I am on Executive Committee for ARISE2 Trial
More informationStandards of excellence
The Accreditation Canada Stroke Distinction program was launched in March 2010 to offer a rigorous and highly specialized process above and beyond the requirements of Qmentum. The comprehensive Stroke
More informationTreatment with intravenous rtpa has proved successful in
ORIGINAL RESEARCH INTERVENTIONAL Mechanical Embolectomy for Acute Ischemic Stroke in the Anterior Cerebral Circulation: The Gothenburg Experience during 2000 2011 A. Rentzos, C. Lundqvist, J.-E. Karlsson,
More informationEVOLUTION IN SYSTEMS OF STROKE CARE RIDWAN LIN, MD, PHD STROKE & INTERVENTIONAL NEUROLOGY BROWARD HEALTH
EVOLUTION IN SYSTEMS OF STROKE CARE RIDWAN LIN, MD, PHD STROKE & INTERVENTIONAL NEUROLOGY BROWARD HEALTH STROKE SYSTEMS OF CARE: 7. Secondary prevention 1. Primary prevention Patient 3. Emergency transport
More information